Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
WEBINAR: Best practices in global flow cytometry quality control and harmonization 11 days 0 hours 5 mins 49 secs REGISTER NOW

Presentation: Metabolomics for discovering the functions of genes with embryonic-lethal mutations (Agilent)

7 Oct 2014
General interest

Presentation held by Steven S. Gross, Department of Pharmacology Weill Cornell Medical College (NY, NY).

sgross

 

Click here to view presentation.

Related Links

  • Agilent Technologies

 

Top content

  • FDA rejects Moderna’s filing for mRNA-1010 flu vaccine
  • Tears tell a story: detecting diabetic retinopathy early
  • New blood test technology accelerates drug detection in critical situations

Related tags

metabolomics
Previous article Next article

Related articles

24 NOV 2014 EXPERT OPINION
Global metabolic profiling – where are we now?
3 OCT 2016 REGULATED BIOANALYSIS
A simple, effective approach for rapid development of high-throughput and reliable LC–MS/MS bioanalytical assays
18 APR 2012 COLLABORATIONS AND MERGERS
Conference Report: Advances in Metabolic Profiling
22 MAR 2019 INTERVIEWS
An author’s perspective: George Jaskiw on quantification of phenolic acid metabolites in humans by LC–MS
4 NOV 2014 CHROMATOGRAPHY
Interview with Adam Rosebrock (University of Toronto) on his metabolomics research
25 MAR 2025 NEWS
Duke-NUS and NUS Medicine introduce Systems Metabolomics Centre to advance precision medicine
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2026 Bioanalysis Zone